milestone pharmaceuticals stock

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Pharmaceuticals in the last year. Top institutional investors include California Public Employees Retirement System (0.21%) and State Street Corp (0.07%). Since then, MIST stock has decreased by 67.8% and is now trading at $6.43. 4 brokerages have issued 1 year target prices for Milestone Pharmaceuticals' stock. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Subscribe to Premium to view Fair Value for MIST. View Milestone Pharmaceuticals' Short Interest. MIST is not currently paying a regular dividend. On average, they anticipate Milestone Pharmaceuticals' share price to reach $13.25 in the next year. All rights reserved. According to analysts' consensus price target of $13.25, Milestone Pharmaceuticals has a forecasted upside of 106.1% from its current price of $6.43. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma. Only 4.16% of the stock of Milestone Pharmaceuticals is held by insiders. Every investor in Milestone Pharmaceuticals Inc. (NASDAQ:MIST) should be aware of the most powerful shareholder... Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. This suggests a possible upside of 106.1% from the stock's current price. Earnings for Milestone Pharmaceuticals are expected to decrease in the coming year, from ($2.18) to ($2.24) per share. The company reported ($0.53) earnings per share for the quarter, missing analysts' consensus estimates of ($0.51) by $0.02. High institutional ownership can be a signal of strong market trust in this company. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Milestone Pharmaceuticals has received 53.04% “outperform” votes from our community. The stock’s $17 average price target suggests a 236% upside from the current share price of $5.08. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View which stocks have been most impacted by the election. マネーフォワード クラウド会計なら複雑な集計は不要!自動で予測給付額を把握できる。. Get short term trading ideas from the MarketBeat Idea Engine. Data may be intentionally delayed pursuant to supplier requirements. Milestone Pharmaceuticals' stock was trading at $5.80 on November 3rd, 2020 when U.S. federal elections occured and Joe Biden was elected president. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. You may vote once every thirty days. Learn more. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. View our full suite of financial calendars and market data tables, all for free. Milestone Pharmaceuticals has a market capitalization of $158.89 million. Milestone Pharmaceuticals does not currently pay a dividend. Do Not Sell My Information. The company earns $-55,230,000.00 in net income (profit) each year or ($3.50) on an earnings per share basis. Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. Fundamental company data and analyst estimates provided by FactSet. 39.42% of the stock of Milestone Pharmaceuticals is held by institutions. Approximately 3.6% of the company's stock are sold short. Looking for new stock ideas? Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Since then, MIST stock has increased by 10.9% and is now trading at $6.43. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. In the past three months, Milestone Pharmaceuticals insiders have not sold or bought any company stock. Based on an average trading volume of 4,870,000 shares, the days-to-cover ratio is presently 0.1 days. ), Milestone Pharmaceuticals has received 54 “underperform” votes. Sign-up to receive the latest news and ratings for MIST and its competitors with MarketBeat's FREE daily newsletter. Milestone Pharmaceuticals' stock was trading at $19.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Currency in USD, Trade prices are not sourced from all markets. View which stocks have been most impacted by COVID-19. Source: Kantar Media. © American Consumer News, LLC dba MarketBeat® 2010-2020. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Milestone Pharmaceuticals' stock was trading at $19.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Milestone Pharmaceuticals' stock is owned by a variety of retail and institutional investors. View analyst ratings for Milestone Pharmaceuticals. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Their forecasts range from $8.00 to $18.00. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. See what's happening in the market right now with MarketBeat's real-time news feed. View insider buying and selling activity for Milestone Pharmaceuticals. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Milestone Pharmaceuticals has received 61 “outperform” votes. View which stocks are hot on social media with MarketBeat's trending stocks report. Want to see which stocks are moving? Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. View analysts' price targets for Milestone Pharmaceuticals. Vote “Outperform” if you believe MIST will outperform the S&P 500 over the long term. Please log in to your account or sign up in order to add this asset to your watchlist. MIST stock was bought by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, and State Street Corp. Company insiders that have bought Milestone Pharmaceuticals stock in the last two years include Holdings A/S Novo, Rtw Investments, Lp, and Stonepine Capital, LP. Some companies that are related to Milestone Pharmaceuticals include Emisphere Technologies (EMIS), Omeros (OMER), Kadmon (KDMN), Kadmon (KDMN), Geron (GERN), Flexion Therapeutics (FLXN), Spectrum Pharmaceuticals (SPPI), VBI Vaccines (VBIV), Basilea Pharmaceutica (BPMUF), XBiotech (XBIT), ZIOPHARM Oncology (ZIOP), IVERIC bio (ISEE), SIGA Technologies (SIGA), Silence Therapeutics (SLN) and Graybug Vision (GRAY). As of September 30th, there was short interest totaling 464,100 shares, a drop of 17.7% from the September 15th total of 563,700 shares. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257

2014 Mercedes E350 Problems, Rolls-royce Wraith Black Badge 2020 Price, Net Profit Margin Tesla, Kahit Isang Saglit Movie, Toyota Japan Cars, Flood Cartoon Drawing, Tc Electronic Finalizer, 2021 Audi Q7 Release Date, G Wagon Amg Price, Escape From La Genius, Icon Pack Studio Pro Apk, Dimplex Revillusion Rbf36, 2005 Toyota Sienna Problems, Florida A&m Application, Ao Smith Signature Water Heater Reset Button, Seattle Seahawks Jersey Schedule 2020, Usi Informatics Schedule, Cerave Cleanser With Salicylic Acid, How Much Muriatic Acid To Lower Alkalinity In Pool, Lg 50un7300aud 50 Inch, Mongoose Mode Bike, I'm Getting Old Quotes, After Earth Trailer, Jimny For Sale In Karachi, Watercolor Ideas For Kids, O Letter Names For Boy In Telugu, Cla Shooting Brake Motability, Agapanthus Not Flowering Australia, Summon Ender Dragon Command, Easy Grammar Grade 3 Student Workbook Pdf,